APA (7th ed.) Citation

Fujii, H., Kimura, H., Kurosaki, M., Hasebe, C., Akahane, T., Yagisawa, H., . . . Kobashi, H. (2018). Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis. Hepatology Research, 48(9), 746. https://doi.org/10.1111/hepr.13070

Chicago Style (17th ed.) Citation

Fujii, Hideki, et al. "Efficacy of Daclatasvir Plus Asunaprevir in Patients with Hepatitis C Virus Infection Undergoing and Not Undergoing Hemodialysis." Hepatology Research 48, no. 9 (2018): 746. https://doi.org/10.1111/hepr.13070.

MLA (9th ed.) Citation

Fujii, Hideki, et al. "Efficacy of Daclatasvir Plus Asunaprevir in Patients with Hepatitis C Virus Infection Undergoing and Not Undergoing Hemodialysis." Hepatology Research, vol. 48, no. 9, 2018, p. 746, https://doi.org/10.1111/hepr.13070.